Quantum Biopharma (QNTM)
NASDAQ:QNTM
Holding QNTM?
Track your performance easily

Quantum Biopharma (QNTM) Income Statement

446 Followers

Quantum Biopharma Income Statement

Last quarter (Q4 2023), Quantum Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Quantum Biopharma's net income was $―. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Aug 17
Total Revenue
-----$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 15.12M$ 19.23M$ 27.48M$ 33.81M$ 30.69M$ 19.37K
Operating Income
$ -15.12M$ -19.23M$ -27.48M$ -33.81M$ -30.69M$ -19.37K
Net Non Operating Interest Income Expense
$ 35.41K$ 786.36K$ 332.94K---
Other Income Expense
$ -9.64K$ -4.77M$ -521.81K$ -682.51K$ -2.57M-
Pretax Income
$ -15.09M$ -18.23M$ -26.59M$ -33.13M$ -28.36M$ -19.37K
Tax Provision
--$ 234.23K$ 858.48K$ 770.87K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -11.55M$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Basic EPS
$ -0.31$ -0.46$ -0.61$ -1.01$ -2.64$ >-0.01
Diluted EPS
$ -0.31$ -0.46$ -0.61$ -1.01$ -2.64$ >-0.01
Basic Average Shares
$ 76.69M$ 39.59M$ 38.73M$ 34.95M$ 12.05M$ 6.57M
Diluted Average Shares
$ 76.69M$ 39.59M$ 38.73M$ 34.95M$ 12.05M$ 6.57M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 15.12M$ 19.23M$ 27.48M$ 33.81M$ 30.69M$ 19.37K
Net Income From Continuing And Discontinued Operation
$ -11.55M$ -17.90M$ -23.61M$ -35.29M$ -31.80M$ -19.37K
Normalized Income
$ -15.05M----$ -19.37K
Interest Expense
$ 32.30K-----
EBIT
$ -15.06M-$ -27.11M$ -33.13M$ -28.36M$ -19.37K
EBITDA
$ -12.78M-$ -22.57M$ -29.09M$ -24.46M$ -19.37K
Currency in USD

Quantum Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis